|
Alltracel Pharmaceuticals researches and develops products for the wound care and dental care markets. The company operates through two main divisions: Alltracel Healthcare Technologies. which develops new medical technology products, and Alltracel Healthcare Group. which then commercializes new products. The company makes the ingredient mdoc which is added to bandages, sprays, and other products to stop bleeding in wounds. The company also markets toothbrushes and dental floss under the Butler and Gum brands. Alltracel has grown through acquisitions and has facilities in China, the Czech Republic, Germany, and Ireland. It was acquired by US-based wound care developer HemCon Medical Technologies in 2008.
|
| | | Contact Information | |
Address: |
Alltracel House, Church Place
Sallynoggin, Dublin, Ireland
| | Phone: | +353-1-235-2162 | | Fax: | +353-1-235-2165 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2008): | 35.70 M | | Employees (2008): | 257 |
|
|
Key People
| | • |
Chairman:
Padraic O'Connor
| | • |
CEO and Director:
Anthony (Tony) Richardson
| | • |
COO; CEO, NANOPEUTICS:
Camillus Glover
|
|
|
